King NM - Search Results

1

What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011.

Henderson GE, Juengst ET, King NM, Kuczynski K, Michie M. Henderson GE, et al. Among authors: king nm. J Law Med Ethics. 2012 Winter;40(4):1008-24. doi: 10.1111/j.1748-720X.2012.00728.x. J Law Med Ethics. 2012. PMID: 23289702 Free PMC article.

2

Genetic research as therapy: implications of "gene therapy" for informed consent.

Churchill LR, Collins ML, King NM, Pemberton SG, Wailoo KA. Churchill LR, et al. Among authors: king nm. J Law Med Ethics. 1998 Spring;26(1):38-47, 3. doi: 10.1111/j.1748-720x.1998.tb01904.x. J Law Med Ethics. 1998. PMID: 11067584

3

Defining and describing benefit appropriately in clinical trials.

King NM. King NM. J Law Med Ethics. 2000 Winter;28(4):332-43. doi: 10.1111/j.1748-720x.2000.tb00685.x. J Law Med Ethics. 2000. PMID: 11317426 Review. No abstract available.

4

Treatments of last resort: informed consent and the diffusion of new technology.

King NM, Henderson G. King NM, et al. Mercer Law Rev. 1991 Spring;42(3):1007-50. Mercer Law Rev. 1991. PMID: 11651433 No abstract available.

5

Studying benefit in gene transfer.

Henderson GE, King NM. Henderson GE, et al. Among authors: king nm. IRB. 2001 Mar-Apr;23(2):13-5. IRB. 2001. PMID: 12825563 No abstract available.

6

Assessing benefits in clinical research: why diversity in benefit assessment can be risky.

Churchill LR, Nelson DK, Henderson GE, King NM, Davis AM, Leahey E, Wilfond BS. Churchill LR, et al. Among authors: king nm. IRB. 2003 May-Jun;25(3):1-8. IRB. 2003. PMID: 14569987 No abstract available.

7

Uncertain benefit: investigators' views and communications in early phase gene transfer trials.

Henderson GE, Davis AM, King NM, Easter MM, Zimmer CR, Rothschild BB, Wilfond BS, Nelson DK, Churchill LR. Henderson GE, et al. Among authors: king nm. Mol Ther. 2004 Aug;10(2):225-31. doi: 10.1016/j.ymthe.2004.05.013. Mol Ther. 2004. PMID: 15294169 Free article.

8

Consent forms and the therapeutic misconception: the example of gene transfer research.

King NM, Henderson GE, Churchill LR, Davis AM, Hull SC, Nelson DK, Parham-Vetter PC, Rothschild BB, Easter MM, Wilfond BS. King NM, et al. IRB. 2005 Jan-Feb;27(1):1-8. IRB. 2005. PMID: 15835063 No abstract available.

9

Therapeutic misconception in early phase gene transfer trials.

Henderson GE, Easter MM, Zimmer C, King NM, Davis AM, Rothschild BB, Churchill LR, Wilfond BS, Nelson DK. Henderson GE, et al. Among authors: king nm. Soc Sci Med. 2006 Jan;62(1):239-53. doi: 10.1016/j.socscimed.2005.05.022. Epub 2005 Jul 5. Soc Sci Med. 2006. PMID: 16000230

10

Vulnerability to influence: a two-way street.

Henderson GE, Davis AM, King NM. Henderson GE, et al. Among authors: king nm. Am J Bioeth. 2004 Summer;4(3):50-2; discussion W32. doi: 10.1080/15265160490497371. Am J Bioeth. 2004. PMID: 16192139 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

400 results

Search Page

Filters